| Alpharma Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110082303 | PROCESS FOR THE MANUFACTURE OF LAIDLOMYCIN - Improved process for the isolation of laidlomycin from a fermentation broth includes increasing the pH of the fermentation broth and centrifuging the pH adjusted fermentation broth, resulting in an aqueous layer and a wet solid layer containing laidlomycin. After the aqueous layer is removed, the wet solid layer containing laidlomycin is dried. The process provides an efficient and high yielding method. | 04-07-2011 |
| 20100143417 | Compositions and methods for controlling diseases in animals - Disclosed herein are compositions for the treatment of a disease in an animal including yeast extract of | 06-10-2010 |
| 20100075398 | Bacteriophage Preparations and Method of Use Thereof - Disclosed herein are purified bacteriophage preparations that effectively lyse a plurality of | 03-25-2010 |
| 20100022634 | Laidlomycin compositions and methods - An animal feed additive composition comprises an effective amount of a laidlomycin, a carrier, magnesium sulfate, and silicon dioxide. Other embodiments include methods of making the animal feed additive compositions, and the use of a laidlomycin in the manufacture of an animal feed additive for increasing the efficiency of feed utilization and rate of weight gain in domestic animals. | 01-28-2010 |
| 20090304793 | SUSTAINED RELEASE OPIOID FORMULATIONS AND METHODS OF USE - The invention combines two different subunits with different release profiles in novel sustained-release oral dosage forms. In particular, the oral dosage forms include a subunit that comprises an opioid analgesic and a sustained-release material, wherein the dissolution rate in-vitro of the subunit, when measured by the standard USP Drug Release test of U.S. Pharmacopeia XXVI (2003) <724>, is less than about 10% within about 6 hours and at least about 60% within about 24 hours; less than about 10% within about 8 hours and at least about 60% within about 24 hours; or less than about 10% within about 12 hours and at least about 60% within about 24 hours; the dosage form providing a duration of therapeutic effect of about 24 hours. | 12-10-2009 |
| 20090155357 | Alcohol Resistant Pharmaceutical Formulations - The present invention provides alcohol resistant oral dosage pharmaceutical forms and methods of using such oral dosage forms to avoid dose dumping if the dosage form is taken together with alcohol. | 06-18-2009 |
| 20090131466 | Pharmaceutical Compositions - Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided. | 05-21-2009 |
